Company Filing History:
Years Active: 2001
Title: Inventor Laurence Colliere: Revolutionizing Pharmaceutical Formulations
Introduction
Laurence Colliere, an innovative inventor based in Montbartier, France, has made significant contributions to the pharmaceutical industry. With a focus on developing stable freeze-dried pharmaceutical formulations, Colliere's work showcases the intersection of science and practicality in medical treatments.
Latest Patents
Colliere holds a patent for a breakthrough in pharmaceutical formulation: a stable freeze-dried formulation that consists of an amorphous phase and a crystalline phase. This formulation is pharmaceutically acceptable and includes at least one nonprotein active ingredient. Notably, it contains mannitol and alanine in a specific ratio (R) between 0.1 and 1, enhancing the stability and efficacy of the product.
Career Highlights
Laurence is currently affiliated with Sanofi-Synthelabo, a prominent pharmaceutical company known for its commitment to innovation and quality in healthcare. His work at Sanofi-Synthelabo reflects his dedication to advancing pharmaceutical science and improving patient outcomes through innovative formulations.
Collaborations
Throughout his career, Colliere has collaborated with notable professionals in the field, including Colette Bouloumie and Thierry Breul. These partnerships reflect a commitment to teamwork and cross-disciplinary efforts that are essential in driving innovation in pharmaceuticals.
Conclusion
Laurence Colliere's contributions to the field of pharmaceutical formulation signify the importance of continuous innovation in healthcare. His patent for a stable freeze-dried formulation represents a potential advancement in the delivery of medical treatments, highlighting the vital role inventors play in shaping the future of medicine.